Because retatrutide is still investigational, important unanswered questions remain about long-term cardiovascular effects, durability of weight loss, ongoing tolerability, and safety across broader patient populations, which is one reason reputable clinics, including Relive Health centers nationwide, are not offering retatrutide at this time
10.1007/s12072-018-9919-1 Hepatol Int
The hypothalamic-pituitary-adrenal (HPA) axis function often changes with chronic psychological stress, sleep deprivation, and depressionconditions themselves linked to weight gain and metabolic disease
While the ongoing SURPASS clinical trial aims to elucidate the mechanistic underpinnings of the drug and the best dosages for treating patients of varying BMIs, its benefits cannot be understated
Yamada et al., 2020b)
That space is where real change can happen, if someone uses it well